Epanova® for Lowering Very High Triglycerides

NCT01242527 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

399

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hypertriglyceridemia

Interventions

DRUG: placebo
DRUG: omefas
DRUG: omefas
DRUG: omefas

Sponsor

AstraZeneca